{
    "organizations": [],
    "uuid": "0eeebe594179fb602ac212d16d91ae597a55c589",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/idUSFWN1RV0Z6",
    "ord_in_thread": 0,
    "title": "REFILE-BRIEF-Sofinnova Partners leads Inventiva Pharma's 35.3 mln euros capital increase",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "(Refiles to correct spelling of “Inventiva”)\nApril 19 (Reuters) - Sofinnova Partners/Inventiva Pharma:\n* Sofinnova Partners, a leading European venture capital firm specialized in Life Sciences, announced today it has led Inventiva Pharma’s (IVA) €35,5 M capital increase through its newly created Sofinnova Crossover I Fund\n* Sofinnova Partners invested €10 M, becoming one of the company’s largest investors\n ",
    "published": "2018-04-19T13:06:00.000+03:00",
    "crawled": "2018-04-20T11:56:34.006+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "refiles",
        "correct",
        "spelling",
        "inventiva",
        "april",
        "reuters",
        "sofinnova",
        "pharma",
        "sofinnova",
        "partner",
        "leading",
        "european",
        "venture",
        "capital",
        "firm",
        "specialized",
        "life",
        "science",
        "announced",
        "today",
        "led",
        "inventiva",
        "pharma",
        "iva",
        "capital",
        "increase",
        "newly",
        "created",
        "sofinnova",
        "crossover",
        "fund",
        "sofinnova",
        "partner",
        "invested",
        "becoming",
        "one",
        "company",
        "largest",
        "investor"
    ]
}